| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | positive regulation of mRNA splicing, via spliceosome | 6.69e-05 | 44 | 37 | 3 | GO:0048026 | |
| GeneOntologyBiologicalProcess | regulation of mRNA splicing, via spliceosome | 8.22e-05 | 129 | 37 | 4 | GO:0048024 | |
| GeneOntologyBiologicalProcess | positive regulation of mRNA processing | 9.25e-05 | 49 | 37 | 3 | GO:0050685 | |
| GeneOntologyBiologicalProcess | leukocyte migration | 1.35e-04 | 449 | 37 | 6 | GO:0050900 | |
| GeneOntologyBiologicalProcess | positive regulation of neutrophil extravasation | 1.40e-04 | 10 | 37 | 2 | GO:2000391 | |
| GeneOntologyBiologicalProcess | regulation of neutrophil extravasation | 1.70e-04 | 11 | 37 | 2 | GO:2000389 | |
| GeneOntologyBiologicalProcess | regulation of mRNA processing | 1.80e-04 | 158 | 37 | 4 | GO:0050684 | |
| GeneOntologyBiologicalProcess | positive regulation of RNA splicing | 1.96e-04 | 63 | 37 | 3 | GO:0033120 | |
| GeneOntologyBiologicalProcess | artery smooth muscle contraction | 2.41e-04 | 13 | 37 | 2 | GO:0014824 | |
| GeneOntologyBiologicalProcess | response to redox state | 2.81e-04 | 14 | 37 | 2 | GO:0051775 | |
| GeneOntologyBiologicalProcess | tonic smooth muscle contraction | 3.24e-04 | 15 | 37 | 2 | GO:0014820 | |
| GeneOntologyBiologicalProcess | mRNA splicing, via spliceosome | 4.23e-04 | 358 | 37 | 5 | GO:0000398 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 4.23e-04 | 358 | 37 | 5 | GO:0000377 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions | 4.45e-04 | 362 | 37 | 5 | GO:0000375 | |
| GeneOntologyBiologicalProcess | neutrophil extravasation | 4.70e-04 | 18 | 37 | 2 | GO:0072672 | |
| GeneOntologyBiologicalProcess | regulation of RNA splicing | 5.02e-04 | 207 | 37 | 4 | GO:0043484 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | 5.35e-04 | 377 | 37 | 5 | GO:0030198 | |
| GeneOntologyBiologicalProcess | extracellular structure organization | 5.42e-04 | 378 | 37 | 5 | GO:0043062 | |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | 5.48e-04 | 379 | 37 | 5 | GO:0045229 | |
| Domain | RBM1CTR | 1.00e-04 | 8 | 36 | 2 | PF08081 | |
| Domain | RBM1CTR | 1.00e-04 | 8 | 36 | 2 | IPR012604 | |
| Domain | MetalloPept_cat_dom | 5.06e-04 | 81 | 36 | 3 | IPR024079 | |
| Domain | - | 5.06e-04 | 81 | 36 | 3 | 3.40.390.10 | |
| Domain | Collagen | 5.83e-04 | 85 | 36 | 3 | IPR008160 | |
| Domain | Collagen | 5.83e-04 | 85 | 36 | 3 | PF01391 | |
| Domain | PG_binding_1 | 6.72e-04 | 20 | 36 | 2 | PF01471 | |
| Domain | Peptidoglycan-bd-like | 6.72e-04 | 20 | 36 | 2 | IPR002477 | |
| Domain | ZINC_PROTEASE | 8.82e-04 | 98 | 36 | 3 | PS00142 | |
| Domain | Hemopexin-like_dom | 8.91e-04 | 23 | 36 | 2 | IPR000585 | |
| Domain | Hemopexin-like_repeat | 8.91e-04 | 23 | 36 | 2 | IPR018487 | |
| Domain | M10A_MMP | 8.91e-04 | 23 | 36 | 2 | IPR033739 | |
| Domain | Hemopexin | 8.91e-04 | 23 | 36 | 2 | PF00045 | |
| Domain | HEMOPEXIN | 8.91e-04 | 23 | 36 | 2 | PS00024 | |
| Domain | - | 8.91e-04 | 23 | 36 | 2 | 2.110.10.10 | |
| Domain | HEMOPEXIN_2 | 8.91e-04 | 23 | 36 | 2 | PS51642 | |
| Domain | HX | 8.91e-04 | 23 | 36 | 2 | SM00120 | |
| Domain | Pept_M10A | 8.91e-04 | 23 | 36 | 2 | IPR021190 | |
| Domain | Peptidase_M10 | 9.71e-04 | 24 | 36 | 2 | PF00413 | |
| Domain | ZnMc | 1.42e-03 | 29 | 36 | 2 | SM00235 | |
| Domain | Peptidase_Metallo | 1.42e-03 | 29 | 36 | 2 | IPR006026 | |
| Domain | C1Q | 1.73e-03 | 32 | 36 | 2 | SM00110 | |
| Domain | C1q | 1.73e-03 | 32 | 36 | 2 | PF00386 | |
| Domain | C1q_dom | 1.95e-03 | 34 | 36 | 2 | IPR001073 | |
| Domain | C1Q | 1.95e-03 | 34 | 36 | 2 | PS50871 | |
| Domain | CYSTEINE_SWITCH | 2.83e-03 | 41 | 36 | 2 | PS00546 | |
| Domain | Pept_M10_metallopeptidase | 3.10e-03 | 43 | 36 | 2 | IPR001818 | |
| Domain | - | 4.18e-03 | 50 | 36 | 2 | 2.60.120.40 | |
| Domain | Tumour_necrosis_fac-like_dom | 5.58e-03 | 58 | 36 | 2 | IPR008983 | |
| Domain | RRM_1 | 7.42e-03 | 208 | 36 | 3 | PF00076 | |
| Domain | RRM | 8.33e-03 | 217 | 36 | 3 | SM00360 | |
| Domain | ConA-like_dom | 8.54e-03 | 219 | 36 | 3 | IPR013320 | |
| Pubmed | 3.87e-08 | 7 | 37 | 3 | 8269511 | ||
| Pubmed | 2.42e-07 | 12 | 37 | 3 | 9598316 | ||
| Pubmed | 3.15e-07 | 13 | 37 | 3 | 10749975 | ||
| Pubmed | 1.10e-06 | 2 | 37 | 2 | 24526468 | ||
| Pubmed | 1.10e-06 | 2 | 37 | 2 | 33942999 | ||
| Pubmed | 1.10e-06 | 2 | 37 | 2 | 28986926 | ||
| Pubmed | 3.30e-06 | 3 | 37 | 2 | 35216088 | ||
| Pubmed | 3.30e-06 | 3 | 37 | 2 | 29218949 | ||
| Pubmed | Phosphorylation of FOXP3 by LCK downregulates MMP9 expression and represses cell invasion. | 3.30e-06 | 3 | 37 | 2 | 24155921 | |
| Pubmed | 6.60e-06 | 4 | 37 | 2 | 20639647 | ||
| Pubmed | Candidate gene association studies in abdominal aortic aneurysm disease: a review and meta-analysis. | 1.65e-05 | 6 | 37 | 2 | 17920311 | |
| Pubmed | 1.65e-05 | 6 | 37 | 2 | 15184870 | ||
| Pubmed | Degeneracy in human multicopy RBM (YRRM), a candidate spermatogenesis gene. | 2.30e-05 | 7 | 37 | 2 | 8875892 | |
| Pubmed | 3.07e-05 | 8 | 37 | 2 | 20302034 | ||
| Pubmed | 3.07e-05 | 8 | 37 | 2 | 15978582 | ||
| Pubmed | Impact of donor-dependent genetic factors on long-term renal graft function. | 3.95e-05 | 9 | 37 | 2 | 19857655 | |
| Pubmed | 4.93e-05 | 10 | 37 | 2 | 10332027 | ||
| Pubmed | Genetic variation associated with preterm birth: a HuGE review. | 6.02e-05 | 11 | 37 | 2 | 16301860 | |
| Pubmed | Assignment of the mouse homologues of 6 loci from HSA1p to chromosomes 3 and 4. | 8.53e-05 | 13 | 37 | 2 | 7829080 | |
| Pubmed | 1.15e-04 | 15 | 37 | 2 | 11804779 | ||
| Pubmed | 1.31e-04 | 16 | 37 | 2 | 10949577 | ||
| Pubmed | 1.43e-04 | 95 | 37 | 3 | 24029230 | ||
| Pubmed | A molecular analysis of matrix remodeling and angiogenesis during long bone development. | 1.48e-04 | 17 | 37 | 2 | 11165481 | |
| Pubmed | 2.07e-04 | 20 | 37 | 2 | 12897243 | ||
| Pubmed | Functional interactions between matrix metalloproteinases and glycosaminoglycans. | 2.51e-04 | 22 | 37 | 2 | 23421805 | |
| Pubmed | 2.51e-04 | 22 | 37 | 2 | 10419448 | ||
| Pubmed | APJ Regulates Parallel Alignment of Arteries and Veins in the Skin. | 2.75e-04 | 23 | 37 | 2 | 25920569 | |
| Pubmed | 2.99e-04 | 24 | 37 | 2 | 15734845 | ||
| Pubmed | 2.99e-04 | 24 | 37 | 2 | 25825872 | ||
| Pubmed | High-resolution photocatalytic mapping of SARS-CoV-2 spike interactions on the cell surface. | 3.13e-04 | 307 | 37 | 4 | 37499664 | |
| Pubmed | 3.52e-04 | 26 | 37 | 2 | 20978081 | ||
| Pubmed | HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137. | 5.28e-04 | 148 | 37 | 3 | 32538781 | |
| Pubmed | 5.35e-04 | 32 | 37 | 2 | 23154389 | ||
| Pubmed | Characterization of long cDNA clones from human adult spleen. | 5.69e-04 | 33 | 37 | 2 | 11214971 | |
| Pubmed | 6.05e-04 | 34 | 37 | 2 | 26378152 | ||
| Pubmed | 6.78e-04 | 36 | 37 | 2 | 20587546 | ||
| Pubmed | Genetic variants in COL2A1, COL11A2, and IRF6 contribute risk to nonsyndromic cleft palate. | 6.78e-04 | 36 | 37 | 2 | 20672350 | |
| Pubmed | The identification of myocilin-associated proteins in the human trabecular meshwork. | 9.23e-04 | 42 | 37 | 2 | 16289162 | |
| Pubmed | 1.02e-03 | 186 | 37 | 3 | 20673868 | ||
| Pubmed | 1.02e-03 | 186 | 37 | 3 | 20452482 | ||
| Interaction | COL4A2 interactions | 1.06e-05 | 75 | 37 | 4 | int:COL4A2 | |
| Cytoband | 17q23.3 | 2.71e-04 | 30 | 37 | 2 | 17q23.3 | |
| Cytoband | 1p34.3 | 1.16e-03 | 62 | 37 | 2 | 1p34.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q25 | 1.94e-03 | 307 | 37 | 3 | chr17q25 | |
| Cytoband | Yq11.223 | 2.58e-03 | 93 | 37 | 2 | Yq11.223 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q23 | 4.25e-03 | 120 | 37 | 2 | chr17q23 | |
| GeneFamily | RNA binding motif containing | 4.04e-04 | 213 | 30 | 4 | 725 | |
| GeneFamily | Endogenous ligands|Matrix metallopeptidases | 7.18e-04 | 24 | 30 | 2 | 891 | |
| Coexpression | HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_28DY_POSITIVE | FKBP9 XXYLT1 BHLHE41 TUBB6 COL24A1 SMPD3 CDC42EP4 MMP9 MIDEAS ST6GALNAC2 SBF2 NRP1 | 5.67e-08 | 1250 | 36 | 12 | M41099 |
| Coexpression | FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP | 6.44e-06 | 88 | 36 | 4 | M19695 | |
| Coexpression | XIE_TRASTUZUMAB_CARDIOTOXICITY_MMU_MIR_483_5P_GENES | 1.00e-04 | 11 | 36 | 2 | MM17503 | |
| Coexpression | GSE360_L_DONOVANI_VS_L_MAJOR_DC_DN | 1.48e-04 | 196 | 36 | 4 | M5194 | |
| Coexpression | GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_24H_UP | 1.57e-04 | 199 | 36 | 4 | M6420 | |
| Coexpression | ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN | 1.59e-04 | 873 | 36 | 7 | M16009 | |
| Coexpression | GSE24634_TREG_VS_TCONV_POST_DAY10_IL4_CONVERSION_DN | 1.60e-04 | 200 | 36 | 4 | M4612 | |
| Coexpression | GSE13306_RA_VS_UNTREATED_TCONV_UP | 1.60e-04 | 200 | 36 | 4 | M3234 | |
| Coexpression | GSE43955_TGFB_IL6_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_52H_DN | 1.60e-04 | 200 | 36 | 4 | M9668 | |
| Coexpression | GSE43955_1H_VS_42H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN | 1.60e-04 | 200 | 36 | 4 | M9680 | |
| Coexpression | GSE27670_CTRL_VS_LMP1_TRANSDUCED_GC_BCELL_DN | 1.60e-04 | 200 | 36 | 4 | M8217 | |
| Coexpression | GSE42088_UNINF_VS_LEISHMANIA_INF_DC_8H_UP | 1.60e-04 | 200 | 36 | 4 | M9909 | |
| Coexpression | GSE17721_0.5H_VS_4H_PAM3CSK4_BMDC_DN | 1.60e-04 | 200 | 36 | 4 | M4108 | |
| CoexpressionAtlas | Myeloid Cells, MF.Thio5.II-480hi.PC, CD115+ MHC II- F480hi Siglec F-, Peritoneal Cavity, avg-3 | 7.88e-06 | 441 | 36 | 7 | GSM605862_500 | |
| ToppCell | B_cells-pDCs|World / Immune cells in Kidney/Urine in Lupus Nephritis | 2.35e-07 | 168 | 36 | 5 | dc8f94424f60ab56facdcffa969e7f3466ee1b6e | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L3_LINC00507_CTXN3|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.04e-07 | 177 | 36 | 5 | 96d639407f79669f3990138793d157b94273581c | |
| ToppCell | IIH-pDC-|IIH / Condition, Cell_class and T cell subcluster | 3.99e-07 | 187 | 36 | 5 | ad87b146ea8dd9f695e722f8f0e8e1057c7f3167 | |
| ToppCell | IIH-pDC|IIH / Condition, Cell_class and T cell subcluster | 3.99e-07 | 187 | 36 | 5 | 5e59e9153a18bcfb5c8dc94599080216661de7ce | |
| ToppCell | MS-pDC-|MS / Condition, Cell_class and T cell subcluster | 4.32e-07 | 190 | 36 | 5 | f56ec302d556ace4f7609017a35c311cf43aa8a5 | |
| ToppCell | MS-pDC|MS / Condition, Cell_class and T cell subcluster | 4.32e-07 | 190 | 36 | 5 | f41d7ab7d7fbcd73fddb6c3533c6a3e642e3d07f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.43e-07 | 191 | 36 | 5 | 04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-Klrb1a/b/c(-)_NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.37e-06 | 165 | 36 | 4 | 651d40eadb1b34de618af94c167f43635729d43f | |
| ToppCell | -SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 1.05e-05 | 170 | 36 | 4 | 601630644f09133ee4c5e64499460b55cf3e80a0 | |
| ToppCell | ICU-SEP-Myeloid-pDC|ICU-SEP / Disease, Lineage and Cell Type | 1.08e-05 | 171 | 36 | 4 | 72c448a0dc4c569bd6b465f9aa395f38034e7ea6 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.13e-05 | 173 | 36 | 4 | 789ab8b2709f4b8728e3733bc72744e9d92ea5ea | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-05 | 174 | 36 | 4 | 9c916af5eebd932f67dc9117e1d26ff194a2ff2c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-05 | 174 | 36 | 4 | bc71521f44a5fe013af42b06b5d1bd2446ecf3b5 | |
| ToppCell | IIF-Myeloid-pDC|IIF / Disease, Lineage and Cell Type | 1.18e-05 | 175 | 36 | 4 | 35cfb7d0b88678ff5b83ad6e19dbc15a908a3fcc | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.18e-05 | 175 | 36 | 4 | 316f2ea930437bf1243b1c0f45e6bd864112c6f2 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.18e-05 | 175 | 36 | 4 | a9f08e1e4c2997dcdd3e5d92daac480da19100b8 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-05 | 176 | 36 | 4 | c6484334187f64cd00cd35e77d8ae436556b4260 | |
| ToppCell | B_cells-pDCs|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 1.21e-05 | 176 | 36 | 4 | ce757de9e09a225f3f96433f103f43619b0e0dda | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Dendritic-plasmacytoid_dendritic_cell|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.29e-05 | 179 | 36 | 4 | 124da6f882968dc0d05f3edd8f3b4d61617cc214 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Dendritic-plasmacytoid_dendritic_cell-DC_c4-LILRA4|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.29e-05 | 179 | 36 | 4 | edc5ef693dc4e7ea70717b77fb908fc784dce3a2 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Dendritic-plasmacytoid_dendritic_cell-DC_c4-LILRA4|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.41e-05 | 183 | 36 | 4 | 3b123571e10c132227aff65648b4b3c6acb4bd00 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Dendritic-plasmacytoid_dendritic_cell|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.41e-05 | 183 | 36 | 4 | df6fd0927b6e4cf9a1583969a68096e4bccfbace | |
| ToppCell | control-Myeloid-pDC|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.50e-05 | 186 | 36 | 4 | fe31e9cf4575ee40b50489593c51d8c36c3cc532 | |
| ToppCell | systemic_lupus_erythematosus-flare-Myeloid-plasmacytoid_dendritic_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.50e-05 | 186 | 36 | 4 | a07694caf7fede06a47636725bcc7f09909cdf07 | |
| ToppCell | Multiple_Sclerosis-Myeloid-pDC|Multiple_Sclerosis / Disease, Lineage and Cell Type | 1.50e-05 | 186 | 36 | 4 | 330a4f669adea91ff9f2dff2de2210f5e3401e19 | |
| ToppCell | healthy_donor-Lymphocytic-Dendritic|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.50e-05 | 186 | 36 | 4 | 916f2aeea4989ba7a29e071e348a51010f010223 | |
| ToppCell | myeloid-Dendritic_cell-Plasmacytoid_dendritic_cell|Dendritic_cell / Lineage, cell class and subclass | 1.50e-05 | 186 | 36 | 4 | 858134580a09ed8a5eb6d6413d8ca9265904dfc1 | |
| ToppCell | control-Myeloid-pDC|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.50e-05 | 186 | 36 | 4 | fccee4cfcc887358cf916d974f29627095b5ad9c | |
| ToppCell | healthy_donor-Lymphocytic-Dendritic-pDC|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.50e-05 | 186 | 36 | 4 | 45f66619e45d590c7365a51782d4ac46b7d31fde | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-05 | 186 | 36 | 4 | 7278a1a1bf9bb27aeb03852134defb31b62f30d6 | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l30|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.53e-05 | 187 | 36 | 4 | 6f7f293c9cf35261e0e3614e46ec1fb00a701b63 | |
| ToppCell | droplet-Heart-4Chambers-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-05 | 187 | 36 | 4 | dba4924d914a7dcd4901142684ba920c2404860b | |
| ToppCell | droplet-Heart-4Chambers-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-05 | 187 | 36 | 4 | 9688141beef4f62613d7a810c5872ccb9afc1a71 | |
| ToppCell | Leuk-UTI-Myeloid-pDC|Leuk-UTI / Disease, Lineage and Cell Type | 1.53e-05 | 187 | 36 | 4 | e3035b1f65ab12b8f01799b8e5d6633b9b584a06 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-mo-Mac|normal_Lymph_Node / Location, Cell class and cell subclass | 1.57e-05 | 188 | 36 | 4 | e83de94a9b47a6a90e98face887eae031a322af6 | |
| ToppCell | Control-Myeloid-pDC|Control / Disease group, lineage and cell class | 1.60e-05 | 189 | 36 | 4 | 46770b99da42f11f10cfc67cea8562342d60b867 | |
| ToppCell | PBMC-Control-Myeloid-pDC|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.63e-05 | 190 | 36 | 4 | adffa93635da10251f28b2089fd96b189775c8b4 | |
| ToppCell | PBMC-Control-Myeloid-pDC-pDC|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.63e-05 | 190 | 36 | 4 | 9a91bf1ea105029e6412d0d9060bca325299ce26 | |
| ToppCell | PBMC-Control-Myeloid-pDC-pDC|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.63e-05 | 190 | 36 | 4 | 39c8ddc2639bf3e986dae11fbae61a735614b604 | |
| ToppCell | PBMC-Control-Myeloid-pDC|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.63e-05 | 190 | 36 | 4 | 2c1c079fd411c03bc3f383aa927eea9446716960 | |
| ToppCell | PBMC-Control-Myeloid-pDC-pDC-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.63e-05 | 190 | 36 | 4 | a95aea3aa707fc4574810706341a5f32b3d00209 | |
| ToppCell | PBMC-Control-Myeloid-pDC-pDC-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.63e-05 | 190 | 36 | 4 | 18dfa84c62dcf081ce9958a71e76a394ec0968e4 | |
| ToppCell | COVID-19_Moderate-pDC|COVID-19_Moderate / disease group, cell group and cell class | 1.67e-05 | 191 | 36 | 4 | 9d0ffa65c547e20b4076fd97776d7738cbd453ec | |
| ToppCell | Healthy-pDC|World / disease group, cell group and cell class | 1.67e-05 | 191 | 36 | 4 | 6e1d825dc33b915b95f13ccd237a552160a4be98 | |
| ToppCell | Healthy-pDC|Healthy / disease group, cell group and cell class | 1.70e-05 | 192 | 36 | 4 | 33d695a28d22b4af111df9591830a33bb7ef7b2d | |
| ToppCell | VE-pDC-|VE / Condition, Cell_class and T cell subcluster | 1.74e-05 | 193 | 36 | 4 | 583724de588fcde3aeda056138c522dc0225a387 | |
| ToppCell | VE-pDC|VE / Condition, Cell_class and T cell subcluster | 1.74e-05 | 193 | 36 | 4 | bb759dc9ef0ec41d655002f59021d62d62d44289 | |
| ToppCell | normal-na-Myeloid-plasmacytoid_dendritic_cell-female|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.77e-05 | 194 | 36 | 4 | 74545942aded51a0f4ee96054b4ce12c4d99a8a0 | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 1.88e-05 | 197 | 36 | 4 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.92e-05 | 198 | 36 | 4 | 36c97eb71b89bac01cabd6a8b728e5a20e52d2a3 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.92e-05 | 198 | 36 | 4 | 50dfe6efca76ea9683a19b6bff59cb5030d346f1 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil-Neu_c2-CXCR4(low)|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.24e-04 | 120 | 36 | 3 | 16c3bd15e3936b68c433c4dd15d655aae64dc960 | |
| ToppCell | Globus_pallidus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.08e-04 | 143 | 36 | 3 | 9bfb3674c8f011b9cf928b522777b8d54478db8d | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.12e-04 | 144 | 36 | 3 | fca32b38d23fa4d213e553b929604a2796e9a929 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_D|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.30e-04 | 148 | 36 | 3 | 10dcbdb47cac908648d9d652c8095b536db19b8a | |
| ToppCell | facs-Lung-3m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.30e-04 | 148 | 36 | 3 | 5983c4546f527a0b599cfcbd8a6cb937a1d6f895 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-NP-L6_NP_ALM_Trh|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.35e-04 | 149 | 36 | 3 | fe9dff31a30dabd212d53d1295f9f13ff32cb217 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_VISp_Krt80_Sla|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.44e-04 | 151 | 36 | 3 | f50c5ae9dae507df750df25e151b58685fec70ce | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.49e-04 | 152 | 36 | 3 | bd1f36b436d8ab7dd8420f595b97d851eab31a38 | |
| ToppCell | 390C-Myeloid-Macrophage-SPP1+_Macrophage_3|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.49e-04 | 152 | 36 | 3 | f717aae4882e9b67e5e40f4ef5b0d35f74a89165 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.49e-04 | 152 | 36 | 3 | ee329249a034a969a16b26a224aa04249d67382d | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-Klrb1a/b/c(-)_NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.54e-04 | 153 | 36 | 3 | cb144b8c487286384b47fdff88ff98fcf0508899 | |
| ToppCell | BAL-Control-cDC_12|Control / Compartment, Disease Groups and Clusters | 2.58e-04 | 154 | 36 | 3 | 0121d08cc527aed9b3e11ff62bb9012916f5c56b | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.68e-04 | 156 | 36 | 3 | 6365b69ede98bc866e996bc52736b00401aacf6f | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Myeloid-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.73e-04 | 157 | 36 | 3 | c8f516d3f5622202d3f8514f68614cd86ea3f667 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Myeloid|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.73e-04 | 157 | 36 | 3 | 4862a11ab8df27d26b4f1c1785e544a2d5b6db6e | |
| ToppCell | facs-Limb_Muscle-Muscle_forelimb_and_hindlimb-18m-Myeloid-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.73e-04 | 157 | 36 | 3 | c3451b33780499fd62672e7cd71c7e8cb6ccc2c5 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_macrophage-microglial_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.73e-04 | 157 | 36 | 3 | d4908cafd8870c1c225817f589ea2bce116ac7ab | |
| ToppCell | facs-Limb_Muscle-Muscle_forelimb_and_hindlimb-18m-Myeloid|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.73e-04 | 157 | 36 | 3 | 92cd58b62e46b93f90e05657fd201404ccae6ddb | |
| ToppCell | facs-Limb_Muscle-Muscle_forelimb_and_hindlimb-18m-Myeloid-macrophage|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.73e-04 | 157 | 36 | 3 | 042129d1b514dc4ed8a5f45b52d9c73cf4807636 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Myeloid-macrophage|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.73e-04 | 157 | 36 | 3 | a0ec1628ce29841889f1d9d4ee9422921af7b0b5 | |
| ToppCell | droplet-Spleen-nan-24m-Myeloid-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.79e-04 | 158 | 36 | 3 | e1a8dba5a88bc3ce112829c5ecb112cbbee5b078 | |
| ToppCell | droplet-Spleen-nan-24m-Myeloid|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.79e-04 | 158 | 36 | 3 | 72e4f8ae137a7dddee0dc6236532e0711065e6af | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_TIP|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.84e-04 | 159 | 36 | 3 | cb2470b288c13e454a2a80115b0d5613b3f718e6 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.0.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.84e-04 | 159 | 36 | 3 | 4b840da854390f8285c219314cff4434d7ffcacc | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.84e-04 | 159 | 36 | 3 | d9e535cf9a0a2302268f2897b010dcecc6426e41 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.84e-04 | 159 | 36 | 3 | 29999c87f5823f734e5cbf8ea8b729ec017db9b3 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.89e-04 | 160 | 36 | 3 | f2cdee5a9e3b0eb125d6be7b5d239eb04333ae41 | |
| ToppCell | COVID_non-vent-Lymphocytic-Dendritic-pDC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.89e-04 | 160 | 36 | 3 | 61f4cb4eb4313d8318aadbb99595a6cb7fd919f7 | |
| ToppCell | COVID_non-vent-Lymphocytic-Dendritic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.89e-04 | 160 | 36 | 3 | 34b4f710cfcb6ec370b8b074f3cbfe272f392cec | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Myeloid-macrophage|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.94e-04 | 161 | 36 | 3 | 787f91f906756ef570c0d02936c3cdfafb3f7454 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Myeloid|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.94e-04 | 161 | 36 | 3 | 3db97af49520dc8cbafb4454d8afd9d588160e89 | |
| ToppCell | facs-MAT-Fat-24m-Myeloid-myeloid_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.94e-04 | 161 | 36 | 3 | 65888250b8c1da6a8f9b5376e086a3769a1cbbd8 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Myeloid-macrophage|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.94e-04 | 161 | 36 | 3 | f1d258c81bcf0f3c52bd20aa58faa9a5fd888168 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.00e-04 | 162 | 36 | 3 | 58da6bc04cdac0002b0e6a751c96ff95e1a7f70f | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_VISp_Ctxn3_Sla|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.00e-04 | 162 | 36 | 3 | 4d13c271b4f63cf32980e5643b5d5951165fe8b5 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Myeloid-neutrophil|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.05e-04 | 163 | 36 | 3 | abec4389cd88252449f110fe95416d67424b403a | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.05e-04 | 163 | 36 | 3 | bbc078761c5043af13d9a6fcf3145a3e300bae5e | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_macrophage-stroma-erythroid_macrophage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.05e-04 | 163 | 36 | 3 | 240d9f0ea45e8b2c7173e7674fd740555810f9e7 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.05e-04 | 163 | 36 | 3 | 8e32b6431e1862572663aa6ddc4ea299c6acc8a6 | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.11e-04 | 164 | 36 | 3 | 057ca87847373eff7fe97dd9f4358509e66ca4c3 | |
| ToppCell | 390C-Lymphocytic-ILC|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.11e-04 | 164 | 36 | 3 | b0fc63b72162b5cc4d1e0a271a12f3d3ab29398f | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Myeloid-neutrophil|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.11e-04 | 164 | 36 | 3 | 8e6dbddacd56a07769163813e3ebfad13302bb62 | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-Klrb1a/b/c(-)_NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.16e-04 | 165 | 36 | 3 | eeb58d4db64ad37dc6b441eab22b05c24862e1a9 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.16e-04 | 165 | 36 | 3 | 84eca6a0f5e996b6955ae79fa102af239098fe8f | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_D3|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.16e-04 | 165 | 36 | 3 | a379fa981db51bec01adea7b1e55e133e15ec383 | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-fibrocyte|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.16e-04 | 165 | 36 | 3 | 8a52f2dbcbd2bc1662b5e3fac381463fdcc3bf14 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.16e-04 | 165 | 36 | 3 | af59a095ecc6758abc13d763c00e44447c488167 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Myeloid-neutrophil|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.16e-04 | 165 | 36 | 3 | 4fe7c3c9370a556cf4e308a2e723b4b907a6cc25 | |
| ToppCell | Influenza_Severe-pDC|World / Disease group and Cell class | 3.22e-04 | 166 | 36 | 3 | bd25ce4c03c3d6cd9d986b9be1d355da52f0f2d7 | |
| Drug | L(-)-vesamicol hydrochloride [112709-59-8]; Up 200; 13.6uM; PC3; HT_HG-U133A | 5.58e-07 | 194 | 36 | 6 | 5056_UP | |
| Drug | Phenformin hydrochloride [834-28-6]; Up 200; 16.6uM; MCF7; HT_HG-U133A | 6.28e-07 | 198 | 36 | 6 | 2312_UP | |
| Drug | CGX 0596987; Down 200; 20uM; PC3; HT_HG-U133A | 1.40e-05 | 197 | 36 | 5 | 6369_DN | |
| Drug | Deoxycorticosterone [64-85-7]; Down 200; 12.2uM; PC3; HT_HG-U133A | 1.40e-05 | 197 | 36 | 5 | 6758_DN | |
| Drug | Spiramycin [8025-81-8]; Down 200; 4.8uM; HL60; HT_HG-U133A | 1.40e-05 | 197 | 36 | 5 | 2558_DN | |
| Drug | Tridihexethyl chloride; Up 200; 11.4uM; PC3; HT_HG-U133A | 1.43e-05 | 198 | 36 | 5 | 5067_UP | |
| Drug | Moricizine hydrochloride [31883-05-3]; Down 200; 8.6uM; HL60; HT_HG-U133A | 1.43e-05 | 198 | 36 | 5 | 2959_DN | |
| Drug | Ketoprofen [22071-15-4]; Up 200; 15.8uM; MCF7; HT_HG-U133A | 1.43e-05 | 198 | 36 | 5 | 2316_UP | |
| Drug | Isopyrin hydrochloride [18342-39-7]; Up 200; 14.2uM; MCF7; HT_HG-U133A | 1.43e-05 | 198 | 36 | 5 | 7233_UP | |
| Drug | fluorophenylalanine | 6.77e-05 | 8 | 36 | 2 | CID000009465 | |
| Drug | AC1L1DD6 | 1.79e-04 | 179 | 36 | 4 | CID000002299 | |
| Drug | Salbutamol [18559-94-9]; Up 200; 16.8uM; PC3; HT_HG-U133A | 2.11e-04 | 187 | 36 | 4 | 3677_UP | |
| Drug | Beclomethasone dipropionate [5534-09-8]; Up 200; 7.6uM; PC3; HT_HG-U133A | 2.29e-04 | 191 | 36 | 4 | 4580_UP | |
| Drug | Ald1.1-H_000455; Up 200; 10uM; MCF7; HT_HG-U133A | 2.29e-04 | 191 | 36 | 4 | 7542_UP | |
| Drug | ICI 182,780; Down 200; 0.01uM; PC3; HT_HG-U133A | 2.34e-04 | 192 | 36 | 4 | 4462_DN | |
| Drug | 15(S)-15-methyl Prostaglandin E2; Up 200; 10uM; PC3; HT_HG-U133A | 2.34e-04 | 192 | 36 | 4 | 7526_UP | |
| Drug | Nimodipine [66085-59-4]; Down 200; 9.6uM; HL60; HT_HG-U133A | 2.38e-04 | 193 | 36 | 4 | 3103_DN | |
| Drug | Penbutolol sulfate [38363-32-5]; Up 200; 5.8uM; MCF7; HT_HG-U133A | 2.38e-04 | 193 | 36 | 4 | 3534_UP | |
| Drug | Dantrolene sodium salt [14663-23-1]; Down 200; 11.8uM; PC3; HT_HG-U133A | 2.38e-04 | 193 | 36 | 4 | 4343_DN | |
| Drug | CP-690334-01 [459212-38-5]; Up 200; 10uM; MCF7; HT_HG-U133A | 2.43e-04 | 194 | 36 | 4 | 3906_UP | |
| Drug | Indoprofen [31842-01-0]; Down 200; 14.2uM; PC3; HT_HG-U133A | 2.43e-04 | 194 | 36 | 4 | 4249_DN | |
| Drug | Racecadotril [81110-73-8]; Down 200; 10.4uM; PC3; HT_HG-U133A | 2.43e-04 | 194 | 36 | 4 | 5755_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A | 2.43e-04 | 194 | 36 | 4 | 2672_DN | |
| Drug | pioglitazone HCl; Up 200; 10uM; MCF7; HT_HG-U133A | 2.43e-04 | 194 | 36 | 4 | 7523_UP | |
| Drug | Tolbutamide [64-77-7]; Up 200; 14.8uM; PC3; HT_HG-U133A | 2.48e-04 | 195 | 36 | 4 | 3804_UP | |
| Drug | Dihydroergotamine tartrate [5989-77-5]; Down 200; 3uM; PC3; HT_HG-U133A | 2.48e-04 | 195 | 36 | 4 | 4502_DN | |
| Drug | 6-Hydroxytropinone [5932-53-6]; Down 200; 25.8uM; PC3; HT_HG-U133A | 2.48e-04 | 195 | 36 | 4 | 4250_DN | |
| Drug | Phenformin hydrochloride [834-28-6]; Up 200; 16.6uM; MCF7; HT_HG-U133A | 2.48e-04 | 195 | 36 | 4 | 4747_UP | |
| Drug | Enilconazole [35554-44-0]; Up 200; 13.4uM; PC3; HT_HG-U133A | 2.48e-04 | 195 | 36 | 4 | 5113_UP | |
| Drug | Hydrastinine hydrochloride [4884-68-8]; Down 200; 16.4uM; MCF7; HT_HG-U133A | 2.48e-04 | 195 | 36 | 4 | 2283_DN | |
| Drug | Phenacetin [62-44-2]; Down 200; 22.4uM; PC3; HT_HG-U133A | 2.48e-04 | 195 | 36 | 4 | 3992_DN | |
| Drug | Cimetidine [51481-61-9]; Up 200; 15.8uM; PC3; HT_HG-U133A | 2.48e-04 | 195 | 36 | 4 | 4063_UP | |
| Drug | chloroprene | 2.52e-04 | 15 | 36 | 2 | CID000031369 | |
| Drug | PD173956 | 2.52e-04 | 15 | 36 | 2 | CID005330524 | |
| Drug | Guanethidine sulfate [60-02-6]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 2.53e-04 | 196 | 36 | 4 | 3171_UP | |
| Drug | Scopolamin-N-oxide hydrobromide [6106-81-6]; Down 200; 10uM; PC3; HT_HG-U133A | 2.53e-04 | 196 | 36 | 4 | 6335_DN | |
| Drug | Furaltadone hydrochloride [3759-92-0]; Down 200; 11uM; HL60; HT_HG-U133A | 2.58e-04 | 197 | 36 | 4 | 2554_DN | |
| Drug | haloperidol; Down 200; 10uM; HL60; HT_HG-U133A | 2.58e-04 | 197 | 36 | 4 | 2704_DN | |
| Drug | Nisoxetine hydrochloride [57754-86-6]; Up 200; 13uM; HL60; HT_HG-U133A | 2.58e-04 | 197 | 36 | 4 | 3117_UP | |
| Drug | Dihydroergotoxine mesylate [8067-24-1]; Up 200; 6.4uM; MCF7; HT_HG-U133A | 2.58e-04 | 197 | 36 | 4 | 4152_UP | |
| Drug | genistein; Down 200; 10uM; HL60; HT_HG-U133A | 2.58e-04 | 197 | 36 | 4 | 2695_DN | |
| Drug | Epiandrosterone [481-29-8]; Up 200; 13.8uM; HL60; HT_HG-U133A | 2.58e-04 | 197 | 36 | 4 | 2444_UP | |
| Drug | Ricinine [524-40-3]; Up 200; 24.4uM; MCF7; HT_HG-U133A | 2.58e-04 | 197 | 36 | 4 | 6067_UP | |
| Drug | Debrisoquin sulfate [581-88-4]; Up 200; 9uM; PC3; HT_HG-U133A | 2.58e-04 | 197 | 36 | 4 | 6688_UP | |
| Drug | Chlormezanone [80-77-3]; Up 200; 14.6uM; PC3; HT_HG-U133A | 2.58e-04 | 197 | 36 | 4 | 4636_UP | |
| Drug | Propidium iodide [25535-16-4]; Up 200; 6uM; PC3; HT_HG-U133A | 2.58e-04 | 197 | 36 | 4 | 5803_UP | |
| Drug | fluphenazine dihydrochloride; Up 200; 10uM; HL60; HT_HG-U133A | 2.63e-04 | 198 | 36 | 4 | 1178_UP | |
| Drug | Flufenamic acid [530-78-9]; Up 200; 14.2uM; PC3; HT_HG-U133A | 2.63e-04 | 198 | 36 | 4 | 5059_UP | |
| Drug | Orphenadrine hydrochloride [341-69-5]; Up 200; 13uM; MCF7; HT_HG-U133A | 2.63e-04 | 198 | 36 | 4 | 3883_UP | |
| Drug | Deferoxamine mesylate [138-14-7]; Up 200; 6uM; MCF7; HT_HG-U133A | 2.63e-04 | 198 | 36 | 4 | 3417_UP | |
| Drug | Amoxapine [14028-44-5]; Up 200; 12.8uM; HL60; HG-U133A | 2.63e-04 | 198 | 36 | 4 | 2013_UP | |
| Drug | Foliosidine [2520-38-9]; Up 200; 13uM; MCF7; HT_HG-U133A | 2.63e-04 | 198 | 36 | 4 | 4761_UP | |
| Drug | Suprofen [40828-46-4]; Down 200; 15.4uM; PC3; HT_HG-U133A | 2.63e-04 | 198 | 36 | 4 | 4005_DN | |
| Drug | Mafenide hydrochloride [138-37-4]; Up 200; 18uM; PC3; HT_HG-U133A | 2.68e-04 | 199 | 36 | 4 | 5079_UP | |
| Drug | Protoveratrine A [143-57-7]; Up 200; 5uM; HL60; HT_HG-U133A | 2.68e-04 | 199 | 36 | 4 | 2144_UP | |
| Drug | 0317956-0000 [391210-11-0]; Up 200; 10uM; PC3; HT_HG-U133A | 2.68e-04 | 199 | 36 | 4 | 3774_UP | |
| Drug | Heliotrine [303-33-3]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 2.68e-04 | 199 | 36 | 4 | 3615_UP | |
| Drug | Antipyrine, 4-hydroxy [1672-63-5]; Down 200; 19.6uM; PC3; HT_HG-U133A | 2.73e-04 | 200 | 36 | 4 | 4095_DN | |
| Drug | Fenbendazole [43210-67-9]; Down 200; 13.4uM; PC3; HT_HG-U133A | 2.73e-04 | 200 | 36 | 4 | 4542_DN | |
| Drug | 1-anilino-4-methyl-2-methylthio-4-phenylimidazolin-5-one | 2.85e-04 | 373 | 36 | 5 | ctd:C540355 | |
| Disease | Down syndrome (is_implicated_in) | 2.04e-05 | 6 | 35 | 2 | DOID:14250 (is_implicated_in) | |
| Disease | angle-closure glaucoma (is_implicated_in) | 2.86e-05 | 7 | 35 | 2 | DOID:13550 (is_implicated_in) | |
| Disease | epilepsy (implicated_via_orthology) | 4.11e-05 | 163 | 35 | 4 | DOID:1826 (implicated_via_orthology) | |
| Disease | Liver diseases | 8.62e-05 | 72 | 35 | 3 | C0023895 | |
| Disease | Liver Dysfunction | 8.62e-05 | 72 | 35 | 3 | C0086565 | |
| Disease | pulmonary emphysema (is_marker_for) | 1.23e-04 | 14 | 35 | 2 | DOID:9675 (is_marker_for) | |
| Disease | ocular hypertension (biomarker_via_orthology) | 1.84e-04 | 17 | 35 | 2 | DOID:9282 (biomarker_via_orthology) | |
| Disease | Alopecia | 2.31e-04 | 19 | 35 | 2 | C0002170 | |
| Disease | systemic scleroderma (is_implicated_in) | 3.71e-04 | 24 | 35 | 2 | DOID:418 (is_implicated_in) | |
| Disease | cataract (is_implicated_in) | 4.36e-04 | 26 | 35 | 2 | DOID:83 (is_implicated_in) | |
| Disease | chronic obstructive pulmonary disease (biomarker_via_orthology) | 5.07e-04 | 28 | 35 | 2 | DOID:3083 (biomarker_via_orthology) | |
| Disease | IGA Glomerulonephritis | 7.49e-04 | 34 | 35 | 2 | C0017661 | |
| Disease | Colonic Neoplasms | 7.77e-04 | 152 | 35 | 3 | C0009375 | |
| Disease | Malignant tumor of colon | 8.85e-04 | 159 | 35 | 3 | C0007102 | |
| Disease | Moyamoya disease | 1.04e-03 | 40 | 35 | 2 | MONDO_0016820 | |
| Disease | congestive heart failure (implicated_via_orthology) | 1.09e-03 | 41 | 35 | 2 | DOID:6000 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GYGGEAEARPDREKG | 241 | Q9C0J9 | |
| EPLDEGGEGGRHAVY | 141 | P78325 | |
| HEGHLDDGGYTPDLK | 126 | P0DJD3 | |
| HEGHLDDGGYTPDLK | 126 | P0DJD4 | |
| HEGHLDDGGYTPDLK | 126 | Q15415 | |
| GVAEHGDGYPFDGKD | 171 | P14780 | |
| GDGYPFDGKDGLLAH | 176 | P14780 | |
| GYPKGHPEAGSFEAD | 196 | P42898 | |
| YIFESKGDGGGGEHP | 431 | Q86VZ4 | |
| EGARPGGIIHVYGDD | 1196 | Q9UPT6 | |
| VGYDHEKPGSGEGLG | 11 | Q86WG5 | |
| SEEDSYDPRGKGGHL | 3291 | Q9UPA5 | |
| AGDSDRGGGPVEHYH | 86 | P50747 | |
| GFPGKDGQDGHDGDR | 61 | Q9BXJ5 | |
| DGGRHGDGYRHPESS | 836 | Q86XP3 | |
| PDGGFATYETKRGGH | 496 | P48449 | |
| SYEPSHDGDLGFEKG | 71 | P06239 | |
| RPCSYGKGGGDAHDE | 591 | Q5JZY3 | |
| EYKGDGGRHPGDEAA | 211 | Q9NY59 | |
| PGYEGEGEGDKNISR | 831 | O14786 | |
| FLAYGEDGDGKDIPG | 226 | O95302 | |
| PDKGKGDGRYGSNDD | 161 | Q8TCZ2 | |
| DPEEGEGGYHGDEGA | 231 | Q9H3Q1 | |
| GLAGDHGEFGEKGDP | 66 | P02746 | |
| VKEEQYLGHEGPGGA | 41 | Q6PJG2 | |
| GGGGENYDDPHKTPA | 86 | P14866 | |
| ADLAHLDDGPYEAGG | 236 | Q13683 | |
| GEADDGPYSKGGKDA | 11 | Q9C0E4 | |
| LEFDGGSRGKGEHFP | 2941 | Q92736 | |
| LEGGEADGDPAHGKD | 491 | P35499 | |
| KADHNDGYPFDGPGG | 191 | Q9ULZ9 | |
| EGLDKGDRPHAYFGP | 251 | Q9UJ37 | |
| GERGEPGAEGYKGHV | 1216 | Q17RW2 | |
| PEKYTGEEDGAGGHS | 801 | O94762 | |
| DAGEAGPKYHDSNRG | 151 | Q6UVY6 | |
| DEHGIDPAGGYVGDS | 26 | Q9BUF5 | |
| AEPYAADEGSGEGHK | 1036 | Q96K76 | |
| AKSLEGGGAGPVDYH | 86 | Q8NBI6 |